Subscribe to receive updates and notifications on Pharmacare publications.
The Pharmacare News Bulletins, which are mailed to pharmacies and prescribers, are listed below. They are an important source of information as they provide timely information on recent changes to the Pharmacare Programs.
Please continue to refer to the Pharmacare News Bulletins to stay current with Formulary and Pharmacare Program updates.
January Bulletin Vol 26-02 (PDF)
New Exception Status Products: Stoboclo (denosumab), Osenvelt (denosumab); Criteria Updates: Nubeqa (darolutamide), Omvoh (mirikizumab), Skyrizi (risankizumab); New Benefit; Compound Billing for Methadone Oral Compound.
January Bulletin Vol 26-01 (PDF)
New Pharmacare Tariff, Pharmacy Services and Community Pharmacy Primary Care Clinic Agreements.
January Bulletin Vol 26-01 (PDF)
New Exception Status Products: Stoboclo (denosumab), Osenvelt (denosumab); Criteria Updates: Nubeqa (darolutamide), Omvoh (mirikizumab), Skyrizi (risankizumab); New Benefit.
Complete Volume Twenty Five 2025 (PDF)
Complete Volume Twenty Four 2024 (PDF)
Complete Volume Twenty Three 2023 (PDF)
Complete Volume Twenty Two 2022 (PDF)
Complete Volume Twenty One 2021 (PDF)
Complete Volume Twenty 2020 (PDF)
Complete Volume Nineteen 2019 (PDF)
Complete Volume Eighteen 2018 (PDF)
Complete Volume Twenty Five 2025 (PDF)
Complete Volume Twenty Four 2024 (PDF)
Complete Volume Twenty Three 2023 (PDF)
Complete Volume Twenty Two 2022 (PDF)
Complete Volume Twenty One 2021 (PDF)
Complete Volume Twenty 2020 (PDF)
Complete Volume Nineteen 2019 (PDF)
Complete Volume Eighteen 2018 (PDF)